Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 28 June 2011, 15:30 HKT/SGT
Share:
    

Source: Hai Kang Life Corporation Limited
Hai Kang Life's EFADchip Technology Featured in Science Magazine

HONG KONG, June 28, 2011 - (ACN Newswire) - Hai Kang Life Corporation Limited ("Hai Kang Life"), a Hong Kong-based biotechnology company founded by professor Albert Cheung-Hoi Yu, has just received significant worldwide attention by being featured in Science magazine, the leading global scientific journal.

The Friday (June 24) issue of Science contained a full page 'News Focus on Biotechnology' article on a revolutionary new lab-on-a-chip technology that is poised to change the current clinical diagnostic paradigm, and put Hong Kong firmly on the international biotech map.

The EFADchip system developed by Hai Kang Life utilizes its propertiary patented technology to detect the presence of a pathogens genetic material in a fraction of the time and with a higher precision than existing tests. This Electric Field Assisted Diagnostic (EFAD) method is also inexpensive, allowing whole at-risk populations to be screened. For example, anyone displaying flu-like symptoms can be tested for the presence of different viruses including H1N1 or SARS. Such screening would allow for accurate disease diagnosis and thus appropriate treatment could be given to patient immediately.

In addition to infectious disease diagnosis, EFADchip can also be used for cancer detection, genetic disease testing, disease surveillance and control, as well as for non-clinical applciations such as veterinary diagnostics, environmental monitoring, testing food for microbial or GMO contamination.

The new EFADchip system comprises of chip and chip-reader ("bio-reader") that can easily be deployed to rural communities where lab facilities are unavailable. In fact, they are so small they can be installed on the office desk top of any doctor. Timely deployment of these units to disease outbreak areas could prevent the development of a global pandemic. According to Zhengping Zhuang, a clinical pathologist at the U.S. National Institutes of Health, who is not connected to Hai Kang Life, the EFADchip and the bio-reader is a unique system and it gets a readout much faster than with other technologies."

Bernard Roizman, a virologist at the University of Chicago in Illinois also comments that the EFADchip system is small in size and effectively it is a lab on a chip on wheels.


Contact:
media@haikanglife.com 


Topic: Research and development
Source: Hai Kang Life Corporation Limited

Sectors: Science & Research, Daily News, BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
SpaceGrime Announces Space Initiative with X  
June 16, 2021 18:00 HKT/SGT
Mitsubishi Corporation Participates in Laos Wind Farm Project  
June 16, 2021 17:00 HKT/SGT
Showa Denko and Seagate to Jointly Develop HAMR-Based HD Media  
June 16, 2021 16:20 HKT/SGT
MUSASHI Launches Blockchain-Based Defi Infrastructure with Innovative Products and Solutions  
June 16, 2021 16:00 HKT/SGT
Star Alliance, NEC and Sita Sign Teaming Agreement, Paving the Way to Expand Touchless Journeys Across Member Airlines  
June 16, 2021 13:15 HKT/SGT
Dynasty expects a 2.2-fold year-on-year revenue growth to over HK$100 million in the first four months of 2021   
June 16, 2021 08:00 HKT/SGT
Future of Crypto Industry, DeFi and NFT Perspectives Were Covered at the Closed Supreme Blockchain Conference in Dubai  
June 15, 2021 21:00 HKT/SGT
World-first Hip Fracture Registry Toolbox striving to improve care for the 1 million+ who fracture a hip in Asia Pacific each year  
June 15, 2021 17:30 HKT/SGT
Clarification Regarding Central Global Bhd's MoU with China's Huobi Mall for the Development of a Global Data Centre in Malaysia  
June 15, 2021 17:00 HKT/SGT
Experience the First-Ever Virtual Rainforest World Music Festival 2021 for Free  
June 15, 2021 17:00 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: